R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 362,522 shares at $14.22 ($3.2M) on 2016-06-01, disclosed to the SEC on 2016-06-01.
Open-market purchase of $3.2M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 110,969 | $0 | 0.0% |
| 2 | $11.43 | 56,739 | $649K | 20.3% |
| 3 | $12.76 | 127,691 | $1.6M | 51.0% |
| 4 | $13.22 | 8,233 | $109K | 3.4% |
| 5 | $13.26 | 28,797 | $382K | 12.0% |
| 6 | $14.11 | 23,890 |
| $337K |
| 10.6% |
| 7 | $14.22 | 6,203 | $88K | 2.8% |
| Total | $8.81 avg | 362,522 | $3.2M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |